Dendritic Cell Vaccination During Lymphoid Reconstruction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This is a randomized, controlled, multicenter, dose-escalation study of fludarabine. Patients are randomized to 1 of 2 treatment arms. The purpose of this study is to find out what side effects are caused in this study and whether Fludarabine with the dendritic cell vaccine (DC vaccine) can increase the ability of the immune system to recognize melanoma.
Epistemonikos ID: 6e0c291159ba37f1c0bc3aea92547fb34808f8d5
First added on: May 04, 2024